Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.430
+0.080 (5.93%)
At close: Apr 17, 2025, 4:00 PM
1.490
+0.060 (4.20%)
After-hours: Apr 17, 2025, 5:54 PM EDT
Autolus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 227.38 | 239.57 | 382.44 | 310.34 | 153.3 | Upgrade
|
| Short-Term Investments | 360.64 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 588.02 | 239.57 | 382.44 | 310.34 | 153.3 | Upgrade
|
| Cash Growth | 145.45% | -37.36% | 23.23% | 102.44% | -27.22% | Upgrade
|
| Accounts Receivable | 0.95 | 1.05 | 0.15 | 0.07 | - | Upgrade
|
| Other Receivables | 47.3 | 23.5 | 28.82 | 26.18 | 29.69 | Upgrade
|
| Receivables | 48.24 | 24.54 | 28.98 | 26.25 | 29.69 | Upgrade
|
| Inventory | 4.14 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 15.21 | 8.64 | 12.34 | 8.71 | 10.21 | Upgrade
|
| Restricted Cash | 1.43 | 0.77 | 0.33 | 0.34 | 0.79 | Upgrade
|
| Other Current Assets | 3.89 | 1.79 | 1.7 | 1.31 | 3.01 | Upgrade
|
| Total Current Assets | 660.93 | 275.3 | 425.77 | 346.95 | 196.98 | Upgrade
|
| Property, Plant & Equipment | 105.05 | 95.65 | 58.42 | 52.32 | 89.68 | Upgrade
|
| Other Intangible Assets | 12.37 | - | - | 0.07 | 0.16 | Upgrade
|
| Long-Term Deferred Tax Assets | 3.24 | 3.06 | 2.08 | 1.83 | 1.75 | Upgrade
|
| Other Long-Term Assets | 1.13 | 1.36 | 4.01 | 4.4 | 5.66 | Upgrade
|
| Total Assets | 782.73 | 375.38 | 490.27 | 405.56 | 294.24 | Upgrade
|
| Accounts Payable | 1.97 | 0.1 | 0.53 | 0.43 | 2.26 | Upgrade
|
| Accrued Expenses | 51.8 | 39.05 | 40.4 | 23.51 | 27.08 | Upgrade
|
| Current Portion of Leases | 3 | 5.05 | 5.04 | 4.45 | 3.59 | Upgrade
|
| Other Current Liabilities | 3.98 | 0.53 | 0.39 | 0.16 | 0.7 | Upgrade
|
| Total Current Liabilities | 60.74 | 44.74 | 46.37 | 28.55 | 33.63 | Upgrade
|
| Long-Term Debt | 244.6 | 170.9 | 125.9 | 47.02 | - | Upgrade
|
| Long-Term Leases | 49.63 | 47.91 | 19.22 | 16.55 | 50.57 | Upgrade
|
| Other Long-Term Liabilities | 0.43 | 0.36 | 0.12 | 0.13 | - | Upgrade
|
| Total Liabilities | 355.4 | 263.91 | 191.6 | 92.24 | 84.21 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,556 | 1,019 | 1,008 | 843.11 | 595.02 | Upgrade
|
| Retained Earnings | -1,099 | -878.56 | -670.18 | -521.34 | -379.24 | Upgrade
|
| Comprehensive Income & Other | -29.06 | -28.87 | -38.78 | -8.45 | -5.74 | Upgrade
|
| Shareholders' Equity | 427.33 | 111.47 | 298.67 | 313.32 | 210.03 | Upgrade
|
| Total Liabilities & Equity | 782.73 | 375.38 | 490.27 | 405.56 | 294.24 | Upgrade
|
| Total Debt | 297.23 | 223.87 | 150.16 | 68.01 | 54.16 | Upgrade
|
| Net Cash (Debt) | 290.79 | 15.7 | 232.28 | 242.32 | 99.14 | Upgrade
|
| Net Cash Growth | 1752.19% | -93.24% | -4.15% | 144.43% | -46.24% | Upgrade
|
| Net Cash Per Share | 1.14 | 0.09 | 2.45 | 3.36 | 1.92 | Upgrade
|
| Filing Date Shares Outstanding | 266.13 | 265.93 | 173.07 | 90.91 | 52.35 | Upgrade
|
| Total Common Shares Outstanding | 266.12 | 174.1 | 173.07 | 90.91 | 52.35 | Upgrade
|
| Working Capital | 600.19 | 230.57 | 379.41 | 318.4 | 163.35 | Upgrade
|
| Book Value Per Share | 1.61 | 0.64 | 1.73 | 3.45 | 4.01 | Upgrade
|
| Tangible Book Value | 414.95 | 111.47 | 298.67 | 313.26 | 209.87 | Upgrade
|
| Tangible Book Value Per Share | 1.56 | 0.64 | 1.73 | 3.45 | 4.01 | Upgrade
|
| Machinery | 50.42 | 38.37 | 35.98 | 38.92 | 27.76 | Upgrade
|
| Construction In Progress | 19.64 | 12.54 | 13.19 | 2.44 | 14.32 | Upgrade
|
| Leasehold Improvements | 14.12 | 12.73 | 11.69 | 14.9 | 10.63 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.